Chuhan Chung Selected Research

Chuhan Chung Research Topics

Disease

18	Fibrosis (Cirrhosis) 03/2023 - 03/2013
10	Non-alcoholic Fatty Liver Disease 01/2023 - 11/2018
9	Liver Cirrhosis (Hepatic Cirrhosis) 03/2023 - 04/2011
6	Neoplasms (Cancer) 10/2016 - 09/2006
4	Sclerosing Cholangitis 03/2023 - 01/2019
4	type 6 Osteogenesis imperfecta 01/2016 - 11/2013
3	Cholestasis 03/2023 - 01/2019
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2019
3	Pruritus (Itching) 01/2023 - 01/2020
3	Liver Diseases (Liver Disease) 01/2023 - 11/2002
3	Inflammation (Inflammations) 11/2022 - 05/2016
3	Carcinoma in Situ 10/2016 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2016 - 05/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014 - 12/2012
2	Insulin Resistance 01/2022 - 12/2012
2	Osteogenesis Imperfecta (Lobstein Disease) 01/2016 - 11/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 01/2008
2	Hepatic Encephalopathy 09/2003 - 01/2003
2	Brain Edema (Cerebral Edema) 08/2003 - 08/2003
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2023
1	Hypertriglyceridemia 01/2023
1	Alcoholic Fatty Liver 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Portal Hypertension 12/2021
1	Disease Progression 01/2021
1	Cholangitis 02/2020
1	Fatty Liver 01/2020
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Cicatrix (Scar) 07/2016
1	Carcinogenesis 05/2016
1	Multiple Fractures 12/2015
1	Bone Diseases (Bone Disease) 12/2015
1	Rare Diseases (Rare Disease) 12/2015
1	Hyperglycemia 04/2014
1	Diabetes Mellitus 12/2012
1	Hypertrophy 10/2012
1	Pancreatitis 12/2011
1	Adenocarcinoma 05/2011

Drug/Important Bio-Agent (IBA)

11	pigment epithelium-derived factorIBA 10/2016 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2013
7	cilofexorIBA 03/2023 - 01/2019
6	Bile Acids and Salts (Bile Acids)IBA 03/2023 - 01/2019
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2018
6	CollagenIBA 01/2022 - 05/2016
5	firsocostatIBA 01/2023 - 11/2018
4	Insulin (Novolin)FDA Link 10/2022 - 12/2012
4	CateninsIBA 10/2016 - 11/2014
4	AmmoniaIBA 12/2004 - 01/2003
3	selonsertibIBA 01/2023 - 01/2021
3	Acetyl-CoA CarboxylaseIBA 01/2023 - 12/2018
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2023 - 01/2019
3	Alanine Transaminase (SGPT)IBA 01/2022 - 02/2020
2	simtuzumabIBA 01/2023 - 01/2022
2	Fenofibrate (CiL)FDA LinkGeneric 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 01/2008
2	BilirubinIBA 12/2021 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 01/2021
2	Alkaline PhosphataseIBA 01/2021 - 02/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2020 - 01/2020
2	CytokinesIBA 05/2016 - 12/2011
2	CeruletideIBA 05/2016 - 12/2011
2	Adenosine Triphosphatases (ATPase)IBA 11/2014 - 05/2011
2	Matrix Metalloproteinases (MMPs)IBA 10/2012 - 05/2011
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2023
1	oxidized low density lipoproteinIBA 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 10/2022
1	glucokinase regulatory proteinIBA 10/2022
1	Oxidants (Oxidizing Agents)IBA 10/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	O(4)-methylthymidine triphosphateIBA 01/2022
1	PalmitatesIBA 01/2022
1	VLDL LipoproteinsIBA 01/2022
1	Deuterium Oxide (Heavy Water)IBA 01/2022
1	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2021
1	Drug CombinationsIBA 01/2021
1	nasIBA 01/2021
1	Keratin-18 (Keratin 18)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2018
1	Protons (Proton)IBA 11/2018
1	Glycoproteins (Glycoprotein)IBA 10/2016
1	Wnt3A ProteinIBA 10/2016
1	LigandsIBA 10/2016
1	IntegrinsIBA 07/2016
1	Peptides (Polypeptides)IBA 01/2015
1	Low Density Lipoprotein Receptor-Related Protein-6IBA 01/2015
1	MineralsIBA 11/2013
1	Carbon Tetrachloride (Tetrachloromethane)IBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2012
1	SerpinsIBA 10/2012
1	Ethanol (Ethyl Alcohol)IBA 12/2011
1	CortactinIBA 05/2011
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 05/2011

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2021
2	Transplantation 02/2020 - 11/2002
2	Surgical Portacaval Shunt (Portacaval Anastomosis) 12/2004 - 08/2003
1	Liver Transplantation 01/2023